Crossmark

Phase I Population Pharmacokinetic Assessment of the Oral Bromodomain Inhibitor OTX015 in Patients with Haematologic Malignancies

Crossref DOI link: https://doi.org/10.1007/s40262-015-0327-6

Published Online: 2015-09-04

Published Print: 2016-03

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Odore, Elodie

Lokiec, François

Cvitkovic, Esteban

Bekradda, Mohamed

Herait, Patrice

Bourdel, Fabrice

Kahatt, Carmen

Raffoux, Emmanuel

Stathis, Anastasios

Thieblemont, Catherine

Quesnel, Bruno

Cunningham, David

Riveiro, Maria E.

Rezaï, Keyvan
License Information

Text and Data Mining valid from 2015-09-04